But GSK was allowed to prepare the materials for the Duke reanalysis, undermining the independence of the process.

FORBES: Steven Nissen: The Hidden Agenda Behind The FDA's New Avandia Hearings

She said the JAMA research was "a reanalysis of old studies" which had been overtaken by other studies, including EPIC.

BBC: NEWS | Health | Fibre cancer benefits questioned